Javier Fernández

• CEO at Vitro Group
• Professor of Entrepreneurship, EMBA. IE Business School
• Co-founder of Bioncotech Therapeutics SL (Valencia, Spain), CNIO's first spin-off
• Co-founder of Artax Biopharmaceuticals Llc (Boston, USA)

Past experience:

-Faculty member at M+Vision Consortium, a biomedical imaging consortium funded by the Madrid Region (CAM) and managed by the Massachusetts Institute of Technology, MIT (Cambridge, USA)

-Co-founder and former Managing Partner (2006-2008) of Suanfarma Biotech SGECR (Spanish 1st VC fund specialised in biotechnology to be approved by Spain's CNMV). Responsible for arranging seed rounds in 3P, Halotech, Vivia Biotech, Pevesa and ClaveSuan SL and then working as Board Director.

-International Partner of Scientifica SAS (Bogotá, Colombia), working as an international expert in finance and entrepreneurship

-Non Executive Director at Angel Biotechnology Holdings Plc (UK), 2004-2008, a company sucessfully floated at London's AIM in 2005. -Area Manager at Suanfarma SA. International trading of pharmaceutical raw materials and finished drugs.

Specialties: Venture capital, biotech start-ups, international business development, development of new biotech&medtech technologies

Education

• Executive MBA IE (Instituto de Empresa) (2002 — 2003)
• ICADE (E-2) Universidad Pontificia Comillas (1989 — 1994)